Nir-Paz Ran
Title
Cited by
Cited by
Year
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune …
DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ...
Clinical cancer research 18 (3), 858-868, 2012
2772012
Factors Predicting Mortality of Patients With Lung Abscess*
B Hirshberg, M Sklair-Levi, R Nir-Paz, L Ben-Sira, V Krivoruk, MR Kramer
Chest 115 (3), 746-50, 1999
1811999
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells
SZ Ben-Sasson, A Hogg, J Hu-Li, P Wingfield, X Chen, M Crank, ...
Journal of Experimental Medicine 210 (3), 491-502, 2013
1462013
Prophage excision activates Listeria competence genes that promote phagosomal escape and virulence
L Rabinovich, N Sigal, I Borovok, R Nir-Paz, AA Herskovits
Cell 150 (4), 792-802, 2012
1452012
Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
D Averbuch, C Hidalgo-Grass, AE Moses, D Engelhard, R Nir-Paz
Emrging Infectious Diseases 17 (6), 1079-1082, 2011
1222011
Group G streptococcal bacteremia in Jerusalem
R Cohen-Poradosu, J Jaffe, D Lavi, S Grisariu-Greenzaid, R Nir-Paz, ...
Emerging infectious diseases 10 (8), 1455, 2004
1162004
Identification of Risk Factors for Infection in an Outbreak of Mycoplasma pneumoniae Respiratory Tract Disease
E Klement, DF Talkington, O Wasserzug, R Kayouf, N Davidovitch, ...
Clinical infectious diseases 43 (10), 1239-1245, 2006
932006
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection
R Nir-Paz, A Michael-Gayego, M Ron, C Block
Clinical microbiology and infection 12 (7), 685-688, 2006
902006
Deep infection by Trichophyton rubrum in an immunocompromised patient
R Nir-Paz, H Elinav, GE Pierard, D Walker, A Maly, M Shapiro, RC Barton, ...
Journal of clinical microbiology 41 (11), 5298-5301, 2003
902003
The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel
S Pereyre, A Charron, C Hidalgo-Grass, A Touati, AE Moses, R Nir-Paz, ...
PloS one 7 (6), e38585, 2012
702012
Imported melioidosis, Israel, 2008
A Cahn, B Koslowsky, R Nir-Paz, V Temper, N Hiller, A Karlinsky, I Gur, ...
Emerging infectious diseases 15 (11), 1809, 2009
68*2009
Clinical and epidemiological aspects of infections caused by Fusarium species: a collaborative study from Israel
R Nir-Paz, J Strahilevitz, M Shapiro, N Keller, A Goldschmied-Reouven, ...
Journal of clinical microbiology 42 (8), 3456-3461, 2004
632004
Listeria monocytogenes multidrug resistance transporters and cyclic di-AMP, which contribute to type I interferon induction, play a role in cell wall stress
MK Zeevi, NS Shafir, S Shaham, S Friedman, N Sigal, RN Paz, IG Boneca, ...
Journal of bacteriology 195 (23), 5250-5261, 2013
522013
Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012
R Nir-Paz, A Abutbul, AE Moses, C Block, C Hidalgo-Grass
Eurosurveillance 17 (8), pii=20095, 2012
462012
Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions--Systematic review and meta-analysis
I Linchevski, E Klement, R Nir-Paz
Vaccine 27 (18), 2437-2446, 2009
442009
Pregnancy-associated listeriosis: clinical characteristics and geospatial analysis of a 10-year period in Israel
H Elinav, A Hershko-Klement, L Valinsky, J Jaffe, A Wiseman, H Shimon, ...
Clinical Infectious Diseases 59 (7), 953-961, 2014
432014
emm typing of M nontypeable invasive group A streptococcal isolates in Israel
AE Moses, C Hidalgo-Grass, M Dan-Goor, J Jaffe, I Shetzigovsky, ...
Journal of clinical microbiology 41 (10), 4655-4659, 2003
412003
Anti-Candida albicans biofilm effect of novel heterocyclic compounds
S Kagan, A Jabbour, E Sionov, AA Alquntar, D Steinberg, M Srebnik, ...
Journal of Antimicrobial Chemotherapy 69 (2), 416-427, 2014
392014
Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination
R Nir-Paz, D Gelman, A Khouri, BM Sisson, J Fackler, S Alkalay-Oren, ...
Clinical Infectious Diseases 69 (11), 2015-2018, 2019
382019
Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures
R Nir-Paz, MC Prévost, P Nicolas, A Blanchard, H Wróblewski
Antimicrobial agents and chemotherapy 46 (5), 1218-1225, 2002
352002
The system can't perform the operation now. Try again later.
Articles 1–20